Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inogen (INGN)
NASDAQ:INGN
Holding INGN?
Track your performance easily
INGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.13 - $13.33
Previous Close$10.25
Volume139.73K
Average Volume (3M)200.52K
Market Cap
$243.12M
Enterprise Value$146.87M
Total Cash (Recent Filing)$117.69M
Total Debt (Recent Filing)$21.44M
Price to Earnings (P/E)―
Beta1.73
Next Earnings
Nov 05, 2024EPS Estimate
-$0.5Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.97
Shares Outstanding23,719,012
10 Day Avg. Volume190,347
30 Day Avg. Volume200,517
Standard Deviation0.18
R-Squared0.10
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)1.32
Price to Sales (P/S)0.76
Price to Cash Flow (P/CF)9.30
P/FCF Ratio13.70
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.45
Enterprise Value/Gross Profit1.16
Enterprise Value/Ebitda-1.82
Forecast
1Y Price Target
$9.50Price Target Upside-6.17% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering3
Inogen News
PremiumPre-Earnings
Inogen Inc (INGN) Q2 Earnings Cheat Sheet
PremiumCompany Announcements
Inogen Announces Executive Departure and Transition Plan
PremiumCompany Announcements
Inogen Announces Executive Leadership Transition and Compensation Plan
PremiumCompany Announcements
Inogen Annual Meeting: Strategic Direction and Governance OutcomesBulls Say, Bears Say
Bulls Say
EarningsINGN's revenue and adjusted EBITDA have consistently beaten consensus estimates.
MarginsGross margin and EBITDA margin have improved significantly as costs eased.
SalesB2B sales exceeded estimates thanks to new customer wins and a modest benefit from Philips exiting the US portable oxygen concentrator market.
Bears Say
Market CompetitionManagement noted that they did not see a significant benefit from Philips exiting the US portable oxygen concentrator market.
ProfitabilityINGN still has a long way to go to reach profitability, and analyst maintains a Hold rating.
SalesDTC sales missed the estimate due to a decline in sales reps and insurance payment rate headwinds.
---
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
INGN FAQ
What was Inogen’s price range in the past 12 months?
Inogen lowest stock price was $4.13 and its highest was $13.33 in the past 12 months.
What is Inogen’s market cap?
Currently, no data Available
When is Inogen’s upcoming earnings report date?
Inogen’s upcoming earnings report date is Nov 05, 2024 which is in 42 days.
How were Inogen’s earnings last quarter?
Inogen released its earnings results on Aug 06, 2024. The company reported -$0.24 earnings per share for the quarter, beating the consensus estimate of -$0.464 by $0.224.
Is Inogen overvalued?
According to Wall Street analysts Inogen’s price is currently Overvalued.
Does Inogen pay dividends?
Inogen does not currently pay dividends.
What is Inogen’s EPS estimate?
Inogen’s EPS estimate is -$0.5.
How many shares outstanding does Inogen have?
Inogen has 23,719,011 shares outstanding.
What happened to Inogen’s price movement after its last earnings report?
Inogen reported an EPS of -$0.24 in its last earnings report, beating expectations of -$0.464. Following the earnings report the stock price went up 35.951%.
Which hedge fund is a major shareholder of Inogen?
Among the largest hedge funds holding Inogen’s share is Royce & Associates LLC. It holds Inogen’s shares valued at 158K.
---
Inogen Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$9.50 (-6.17% Downside)
$9.50 (-6.17% Downside)
Blogger Sentiment
Bullish
INGN Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 49.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 4.8%
Last 30 Days ▼ 4.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
96.73%
12-Months-Change
Fundamentals
Return on Equity
-39.99%
Trailing 12-Months
Asset Growth
-17.48%
Trailing 12-Months
Company Description
Inogen
Inogen, Inc . engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products consists of Inogen One G4 system, Inogen One G3 system, Inogen One G2 system, and Inogen at Home. The company was founded by Alison Perry, Alison Bauerlein, Brenton Taylor and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
---
INGN Company Deck
---
INGN Earnings Call
Q2 2024
0:00 / 0:00
---
INGN Stock 12 Month Forecast
Average Price Target
$9.50
▼(-6.17% Downside)
Technical Analysis
Best Analysts Covering INGN
1 Year
1 Year Success Rate
11/17 ratings generated profit
1 Year Average Return
+24.19%
reiterated a sell rating 2 months ago
Copying Robbie Marcus's trades and holding each position for 1 Year would result in 64.71% of your transactions generating a profit, with an average return of +24.19% per trade.
---